Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| RAPID MICRO BIOSYSTEMS, INC.RPID · Entity 6966 | CHIEF COMMERCIAL OFFICER | February 11, 2022 | February 15, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
RAPID MICRO BIOSYSTEMS, INC.
Report date February 11, 2022 · Filed February 15, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 43,750 |
Reported balance
After 2022-02-11 transaction · row 1
1 source rowRow 1 · 2022-02-11 · Grant · Acquired 43,750 · Balance 43,750 F1: Grant of restricted stock units ("RSUs") that vest in three annual installments with 33.4% vesting on the first anniversary of February 11, 2022 (the "grant date") and 33.3% vesting on each of the second and third anniversaries of the grant date provided that the Reporting Person remains in continuous service on each vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.82 · Expires 2032-02-10 | Direct | 87,500 |
Reported balance
After 2022-02-11 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-02-11 · Grant · Acquired 87,500 · Balance 87,500 F2: The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 11, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units ("RSUs") that vest in three annual installments with 33.4% vesting on the first anniversary of February 11, 2022 (the "grant date") and 33.3% vesting on each of the second and third anniversaries of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
F2: The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 11, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2022 Filed Feb 15, 2022 19:37 UTC | RAPID MICRO BIOSYSTEMS, INC. RPID · Entity 6966 | GrantStock Option (Right to Buy) · Derivative | 87,500 | $0.00 Strike: $7.82 | $0.00 |
DisclosureSEC source: 0001127602-22-005151 · form4.xml · derivative · entry 2 KEYS RICHARD A · CIK 0001886207 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Underlying: Class A Common Stock · 87,500 shares Expires 2032-02-10 F2 · derivative.exercise_date: The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 11, 2022. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 19:37 UTC | RAPID MICRO BIOSYSTEMS, INC. RPID · Entity 6966 | GrantClass A Common Stock | 43,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-005151 · form4.xml · nonDerivative · entry 1 KEYS RICHARD A · CIK 0001886207 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,750 F1 · shares: Grant of restricted stock units ("RSUs") that vest in three annual installments with 33.4% vesting on the first anniversary of February 11, 2022 (the "grant date") and 33.3% vesting on each of the second and third anniversaries of the grant date provided that the Reporting Person remains in continuous service on each vesting date. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 17:55 UTC | RAPID MICRO BIOSYSTEMS, INC. RPID · Entity 6966 | GrantStock Option · Derivative | 180,000 | $0.00 Strike: $18.43 | $0.00 |
DisclosureSEC source: 0001104659-21-123232 · tm2129262-2_4seq1.xml · derivative · entry 1 KEYS RICHARD A · CIK 0001886207 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 Underlying: Class A Common Stock · 180,000 shares Expires 2031-10-01 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on October 1, 2022 and in 36 substantially equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.